Clinical Trial Update: N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating N-acetylcysteine and aspirin as adjunctive treatment for bipolar disorder completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Aspirin (Aspirin)
• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Bipolar Disorder | Phase 2 | Status: COMPLETED | Results posted: 2018-04-30